Mizzou Students Throw Support Behind Medical Pot Initiative: 'It's Just a Plant'
*By Carlo Versano*
On Tuesday, Missouri could become the 32nd state in the U.S. to legalize medical marijuana.
On the ballot are three proposals on the issue ー regarding regulation, taxation, and the distribution of tax revenues. The amendments are byzantine and confusing, but if one passes, medical marijuana will become the law of the land in the "Show-Me" State.
Cannabis legalization has garnered more public support in recent years, and medical pot is often thought to be the gateway to fuller legalization. While the Missouri medical community is [split](https://kcmedicine.org/survey-results-physician-attitudes-medical-marijuana/) on the drug's medicinal value, much of the student body at the University of Missouri has a pro-legalization stance.
CheddarU went to Mizzou's campus to hear what students had to say ahead of the vote.
"I just can't see any good reason not to have it medicinally available here," said In'lana Henderson, VP of Students for Sensible Drug Policy at Mizzou.
"People think that it's very taboo here," she added.
That possibility that Missouri, a reliably red state in the country's heartland, could pass a progressive drug law, gives some students hope that the end result could galvanize public support for cannabis legalization.
"I think that if we can legalize it, it will help other states do that, too," freshman Payton Nichols-Pittman said.
Or, as senior Meg Rogers put it: "It's just something that we don't need to make people feel bad for."
She added: "It's just a plant."
Chris Versace, CIO at Tematica Research, joins to discuss earnings season trends, Flash PMI signals, Walmart’s strategy updates, and Nike’s evolving outlook.
Andrew Nusca, Editorial Director at Fortune, dives into WhatsApp’s first-ever ads rollout —and how Meta’s ad push intensifies its showdown with OpenAI.
Ben Geman, Energy Reporter at Axios, joins to discuss the latest Middle East tensions, Brent crude price swings, and why gas prices aren’t falling with oil.
Al Root, Associate Editor at Barron's, joins to discuss Tesla’s robotaxis going live in Texas—what it means for autonomy, safety, and the EV race ahead.
Dena Jalbert, M&A expert and CEO of Align Business Advisory Services, on the state of U.S. M&A: deals worth $1–$10 billion (including debt) are surging.
Jeremy Jansen, Head of Supply Chain at Wells Fargo, unpacks the ongoing trade talks between the United States and China as consumers still wonder about tariffs.
A group of Democratic Texas lawmakers is asking Elon Musk to delay his rollout of driverless ‘robotaxis’ in the state this weekend to assure the vehicles are safe enough.
The billionaire slated to takeover the controlling interest in the Los Angeles Lakers has built a career leading businesses investing in everything from sports franchises to artificial intelligence.
